N
OPTN

Nuveen’s OptiNose OPTN Stock Holding History

Nuveen’s Portfolio OPTN Stock Details OPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-7,479
Closed -$164K – 3393
2024
Q1 		$164K Hold
7,479
– – ﹤0.01% 3212
2023
Q4 		$145K Buy
7,479
+666
+10% +$12.2K ﹤0.01% 3250
2023
Q3 		$126K Hold
6,813
– – ﹤0.01% 3105
2023
Q2 		$126K Buy
+6,813
New +$161K ﹤0.01% 3144
2021
Q2 		– Sell
-14,108
Closed -$781K – 3491
2021
Q1 		$781K Sell
14,108
-2,036
-13% -$124K ﹤0.01% 2973
2020
Q4 		$1M Buy
16,144
+1,795
+13% +$110K ﹤0.01% 2806
2020
Q3 		$840K Buy
14,349
+47
+0.3% +$3.48K ﹤0.01% 2758
2020
Q2 		$1.6M Buy
14,302
+3,405
+31% +$242K ﹤0.01% 2433
2020
Q1 		$734K Buy
10,897
+1,838
+20% +$185K ﹤0.01% 2639
2019
Q4 		$1.25M Buy
9,059
+3,499
+63% +$454K ﹤0.01% 2607
2019
Q3 		$584K Sell
5,560
-286
-5% -$28.5K ﹤0.01% 2891
2019
Q2 		$621K Buy
+5,846
New +$770K ﹤0.01% 2938
2018
Q4 		– Sell
-10,181
Closed -$1.9M – 1049
2018
Q3 		$1.9M Buy
10,181
+3,616
+55% +$1.03M 0.01% 656
2018
Q2 		$2.75M Buy
+6,565
New +$2.21M 0.02% 577

Other funds holding OPTN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Nuveen's OPTN Position: Q2 2024 in Review

Nuveen sold out of OptiNose (OPTN) in Q2 2024, closing a stake of 7,479 shares — an estimated $164K sold.

Nuveen first reported a position in OPTN in Q2 2018 and held it in 14 quarters. The position peaked at $2.75M in Q2 2018. 84 funds tracked by Wall St. Rank hold OPTN as of Q2 2024.

  • Nuveen reported no remaining OptiNose position as of Q2 2024 after selling out during the quarter.
  • Nuveen sold 7,479 OptiNose shares in Q2 2024, an estimated $164K.
  • Nuveen first reported a position in OptiNose in Q2 2018 and held it in 14 quarters.
  • Nuveen's OptiNose position peaked at $2.75M in Q2 2018.
  • 84 funds tracked by Wall St. Rank held OptiNose as of Q2 2024.

Based on Nuveen's 13F filing for Q2 2024, filed 9 Aug 2024.